Article Text

Download PDFPDF
Treatment of hip osteoarthritis with glucocorticoids
  1. Jian Zhou1,2,
  2. Biao Liu3,
  3. Chenxi Li4,
  4. Yingquan Luo5,
  5. Tang Liu1,
  6. Wanchun Wang1
  1. 1 Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China
  2. 2 Department of Sports Medicine Research Center, Central South University, Changsha, China
  3. 3 Department of Orthopedics, Hukou County Hospital of traditional Chinese Medicine, Jiujiang, China
  4. 4 Department of Clinical Medicine, School of Medicine, Shandong University, Jinan, China
  5. 5 Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, China
  1. Correspondence to Prof Yingquan Luo, Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; luoyingquan{at}csu.edu.cn and Prof Tang Liu and Professor Wanchun Wang, Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; liutang1204{at}csu.edu.cn, wanchun.wang{at}csu.edu.cn

Statistics from Altmetric.com

Osteoarthritis (OA), also known as degenerative joint disease, hypertrophic arthritis, senile arthritis and articular cartilage osteoarthritis, is a common clinical disease. The common symptoms of OA include pain in affected joints, aggravation after exercise, remission after rest and a feeling of stiffness without activity for a long time.1 OA can occur in any joint, but mainly in the hip joint, knee joint, hand joint and spine facet joint. Recently, it was with great interest that we read the report entitled ‘Intramuscular glucocorticoid injection versus placebo injection in hip osteoarthritis: a 12 week blinded randomised controlled trial’ by Dorleijn and colleagues published online in 7 March 2018 in Annals of the Rheumatic Diseases.2 Dorleijn et al concluded that an intramuscular glucocorticoid injection showed effectiveness in patients with hip OA on one of the three primary outcomes at 2 weeks postinjection and all primary outcomes showed effectiveness from 4 to 6 weeks. Certainly, the study of Dorleijn et al will be important for …

View Full Text

Footnotes

  • Contributors All authors were involved in the study conception, manuscript drafting and revising, and final approval of the submitted version.

  • Funding This work was supported by the Fundamental Research Funds for the Central Universities of Central South University (grant no. 2018zzts930), the Central South University Sports Medicine Scholarship and the National Natural Science Foundation of China (grant nos. 81000821 and 81672176).

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.